Topical Multiple Ascending Dose Study for PF-06423264

NCT02778477 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

65

Enrollment

INDUSTRY

Sponsor class

Stopped Preliminary analysis of accrued data failed to indicate any meaningful pharmacodynamic response.

Conditions

Normal Healthy

Interventions

DRUG: PF-06423264
OTHER: Placebo

Sponsor

Pfizer